Today, the United Network for Organ Sharing (UNOS) announced that Paul Rocheleau has joined its Board of Directors.
Rocheleau has decades of experience leading and operating global corporations, life sciences ventures, research-university initiatives and nonprofit entities, and brings a strategic insight that has helped organizations identify opportunities and grow.
He played a significant role in advancing life sciences and high-skilled talent development initiatives in Virginia. As co-founder of Virginia Life Science Investments, LLC, Rocheleau helped attract international startups to the Commonwealth and launch early-stage operations. From 1997 to 2023, he helped establish and grow the College of Engineering at Virginia Commonwealth University, where he served on its foundation and as executive director of strategic programs. While with the university, he created industry partnerships, assisted economic development efforts, and secured public and private funding.
“Paul’s extensive leadership involving life science startups, technology commercialization and global business initiatives will bring a valuable perspective to the UNOS board,” said Mark Johnson, interim CEO of UNOS. “His experience guiding complex organizations through periods of growth and innovation will be highly valued as we enhance the ways we serve the organ donation and transplant system.”
Rocheleau retired in 2024 following a distinguished career. He has held senior executive roles including chief executive officer of Albright & Wilson, a London-based multinational chemical company, and chief financial officer of Albemarle Corp., a global specialty chemicals company. In these roles, he developed and implemented disruptive business strategies, commercialized new technology, created strategic partnerships, and secured funding for acquisitions to support rapid growth.
He has served on the boards of public multinational companies, nonprofit organizations and private companies, including Richmond-based Apex Systems Inc.
“I am honored to join the UNOS board and support its mission to save and improve lives,” Rocheleau said. “I look forward to contributing to the organization’s critically important work as it expands and engages partners across a very complex ecosystem that defines the organ donation and transplant community.”
Rocheleau will begin his term on June 1, 2026, serving until September 30, 2029. He was unanimously approved by a full board vote on May 18, 2026.
